Skip to content

Chandraprabha varti(ointment)in Arma (Pterygium)

Clinical Evaluation of Chandraprabha Varti (ointment) in Arma(Pterygium)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045140
Enrollment
30
Registered
2022-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

None listed

Sponsors

Gurukul campus UAU haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pateint presenting With clinical features of Arma (Pterygium)as per classic Pterygium encroaching upto limbal area Primary pterygium Progressive and Regressive pterygium

Exclusion criteria

Exclusion criteria: 1.Patient not willing for trail 2.Patient with any other ocular disorder 3.Pterygium encroaching the cornea,pupillary margin(undilated pupil) 4.Patient presenting with pseudo pterygium and pinguecula 5.Patient with K/C/O of Dibetic Retinopathy and Hypertension Retinopathy 6.Pateint suffering from Rheumatoid Arthritis 7.Patient who have undergone excision of Pterygium.

Design outcomes

Primary

MeasureTime frame
The improvement will be assessed on the basis of 1)subjective parameters Congestion in bulbar conjunctiva,foreign body sensation,watering from eyes. 2) Objective Parameters Length & Thickness of pterygium and TBUTTimepoint: patients will be assessed on 1st ,30th and 60th day

Secondary

MeasureTime frame
The improvement will be assessed on the basis of Subjective and objective parameters Subjective parameters- congestion on bulbar conjunctiva, foreign body sensation, Watering from eyes Objective Parameters: Length and Thickness of pterygium and TBUTTimepoint: 1.15th day after completion of trial. 2.30th day after completion of trial.

Countries

India

Contacts

Public ContactRadha Krishna Bishwal

Gurukul campus UAU haridwar

drbishwal72@gmail.com9870649106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026